Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_27017 | 17 | 0.35 | Mlig455_006914 | Neo: - Age: Up-Down-Up |
PCDH9 | Mlig455_006914 {REF} {Length: 3947} {Pfam: Cadherin domain [PF00028.19, score=321.7]; Cadherin-like [PF08266.14, score=27.2]; Myc target protein 1 [PF15179.8, score=20.1]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=297, Expect=4e-84]; ENSG00000156453, PCDH1, protocadherin 1, [Score=296, Expect=8e-83]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=293, Expect=2e-81]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=292, Expect=5e-81]; ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=289, Expect=2e-79]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=296, Expect=5e-83]; ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=290, Expect=2e-80]; ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=289, Expect=2e-81]; ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=282, Expect=2e-77]} {Dmel: FBgn0284247, ds, dachsous, [Score=259, Expect=4e-70]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=210, Expect=7e-55]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [RH, Score=362, Expect=2e-108]} {RNA1310_32970} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.689 | 0.692 | 0.99972 | 1.00000 | |
RegionR2 | 1.515 | 0.692 | 0.99961 | 1.00000 | |
RegionR3 | -0.528 | 0.692 | 0.99971 | 1.00000 | |
RegionR4 | 0.07 | 0.692 | 0.99970 | 1.00000 | |
RegionR5 | -0.457 | 0.692 | 0.99991 | 1.00000 | |
RegionR6 | -1.142 | 0.692 | 1.00000 | 1.00000 | |
RegionR7 | -0.613 | 0.692 | 0.99988 | 1.00000 | |
RegionR8 | 0.466 | 0.692 | 0.99951 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -2.107 | 0.692 | 0.99990 | 1.00000 | |
RegenerationR2 | 0.037 | 0.692 | 0.37916 | 0.80104 | |
RegenerationR3 | 0.783 | 0.692 | 0.51353 | 0.86364 | |
RegenerationR4 | -1.43 | 0.692 | 1.00000 | 1.00000 | |
RegenerationR5 | -1.196 | 0.692 | 1.00000 | 1.00000 | |
RegenerationR6 | 3.451 | 0.692 | 0.99951 | 1.00000 | |
RegenerationBL | -1.571 | 0.692 | 1.00000 | 1.00000 | |
RegenerationTP | -1.101 | 0.692 | 0.99988 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_27017 | 17 | 0.35 | Mlig455_006914 | Neo: - Age: Up-Down-Up |
PCDH9 | 1 | - | - | - | - | 1.000 | - | Mlig455_006914 {REF} {Length: 3947} {Pfam: Cadherin domain [PF00028.19, score=321.7]; Cadherin-like [PF08266.14, score=27.2]; Myc target protein 1 [PF15179.8, score=20.1]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=297, Expect=4e-84]; ENSG00000156453, PCDH1, protocadherin 1, [Score=296, Expect=8e-83]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=293, Expect=2e-81]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=292, Expect=5e-81]; ENSG00000166341, DCHS1, dachsous cadherin-related 1, [Score=289, Expect=2e-79]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [Score=296, Expect=5e-83]; ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=290, Expect=2e-80]; ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=289, Expect=2e-81]; ENSMUSG00000036862, Dchs1, dachsous cadherin related 1, [Score=282, Expect=2e-77]} {Dmel: FBgn0284247, ds, dachsous, [Score=259, Expect=4e-70]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=210, Expect=7e-55]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [RH, Score=362, Expect=2e-108]} {RNA1310_32970} |
2. | MligTC455_21859 | 8 | 0.16 | Mlig455_046094 | Neo: - Age: - |
SSTR4 | 0.995 | - | - | - | - | 0.995 | - | Mlig455_046094 {REF} {Length: 1678} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=76.6]} {Human: ENSG00000132671, SSTR4, somatostatin receptor 4, [Score=75.1, Expect=3e-14]} {Mouse: ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=82.4, Expect=9e-17]} {Dmel: FBgn0250910, Octbeta3R, Octopamine beta3 receptor, [Score=52.4, Expect=4e-07]} {Celegans: WBGene00020712, ckr-1, CholecystoKinin Receptor homolog, [Score=50.4, Expect=1e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [RH, Score=135, Expect=3e-36]} {RNA1310_148409} |
3. | MligTC455_47945 | 22 | 0.45 | Mlig455_056411 | Neo: - Age: logFC(26M/2M)=1.807 |
0.995 | - | - | - | - | 0.995 | - | Mlig455_056411 {REF} {Length: 2753} {Pfam: Deoxynucleoside kinase [PF01712.21, score=47.4]; Thymidylate kinase [PF02223.19, score=21.0]} {RNA1509_50096} {RNA1310_19543} {RNA815_21860} | |
4. | MligTC455_13221 | 46 | 0.95 | Mlig455_061047 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_061047 {REF} {Length: 1448} {NoTransDecoderORF} {RNA1310_147989} | |
5. | MligTC455_53623 | 66 | 1.37 | Mlig455_062576 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_062576 {REF} {Length: 3190} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=87.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=77.7]} {Dmel: FBgn0029723, Proc-R, Proctolin receptor, [RH, Score=76.6, Expect=1e-14]} {Celegans: WBGene00010986, sprr-1, Sex Peptide Receptor (Drosophila) Related, [Score=93.2, Expect=3e-20]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [Score=141, Expect=4e-38]} {RNA1509_25415} {RNA1310_42304} {RNA815_54656} | |
6. | MligTC455_21038 | 10 | 0.22 | Mlig455_026297, Mlig455_052713 | Neo: - Age: - |
GLRA2 | 0.979 | - | - | - | - | 0.979 | - | Mlig455_026297 {REF} {Length: 3375} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=137.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=102.8]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=259, Expect=5e-80]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=258, Expect=2e-79]; ENSG00000109738, GLRB, glycine receptor beta, [Score=257, Expect=1e-78]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=253, Expect=4e-78]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=5e-76]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=259, Expect=6e-80]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=253, Expect=3e-77]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=253, Expect=1e-77]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=250, Expect=4e-76]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=8e-76]} {Dmel: FBgn0024963, GluClalpha, [Score=245, Expect=6e-75]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [Score=241, Expect=2e-73]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=280, Expect=1e-88]} {RNA1310_99355} Mlig455_052713 {REF} {Length: 1407} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=139.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=78.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=259, Expect=3e-82]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=253, Expect=5e-80]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=252, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=2e-78]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=258, Expect=4e-82]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=253, Expect=5e-80]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=252, Expect=2e-79]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-78]} {Dmel: FBgn0024963, GluClalpha, [Score=238, Expect=5e-76]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [Score=238, Expect=2e-74]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=275, Expect=4e-89]} {RNA1310_135132} |
7. | MligTC455_31074 | 50 | 1.04 | Mlig455_061369 | Neo: - Age: - |
MAN2C1 | 0.979 | - | - | - | - | 0.979 | - | Mlig455_061369 {REF} {Length: 4885} {TRANSSPLICED} {Pfam: Glycosyl hydrolases family 38 N-terminal domain [PF01074.24, score=252.5]; Glycosyl hydrolases family 38 C-terminal domain [PF07748.15, score=92.6]; Alpha mannosidase middle domain [PF09261.13, score=67.9]} {Human: ENSG00000140400, MAN2C1, mannosidase alpha class 2C member 1, [RH, Score=611, Expect=0.0]} {Mouse: ENSMUSG00000032295, Man2c1, mannosidase, alpha, class 2C, member 1, [RH, Score=605, Expect=0.0]} {Smed: dd_Smed_v6_7449_0_11, dd_Smed_v6_7449_0_11, [RH, Score=734, Expect=0.0]} {RNA1509_13703} {RNA1310_2504.1, RNA1509_13703} {RNA1509_13703, RNA815_715} |
8. | MligTC455_12687 | 7 | 0.15 | Mlig455_016746, Mlig455_016758 | Neo: - Age: Up-Down-Up |
CACNA1C, CACNA1D | 0.977 | - | - | - | - | 0.977 | - | Mlig455_016746 {REF} {Length: 8806} {Pfam: Ion transport protein [PF00520.33, score=816.5]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.9]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=91.0]; Polycystin cation channel [PF08016.14, score=23.2]; Protein trafficking PGA2 [PF07543.14, score=19.7]} {Human: ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [RH, Score=1801, Expect=0.0]; ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [RH, Score=1801, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [RH, Score=1757, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [RH, Score=1723, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [RH, Score=1806, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [RH, Score=1753, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [RH, Score=1718, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [RH, Score=1899, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [RH, Score=1809, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_27, dd_Smed_v6_8899_0_27, [RH, Score=1934, Expect=0.0]} {RNA1509_7565} {RNA1310_546.1} {RNA815_3074} Mlig455_016758 {REF} {Length: 716} {Human: ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=52.4, Expect=3e-07]} {Mouse: ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=50.1, Expect=1e-06]} {RNA1509_7565} {RNA1310_1492.2} {RNA815_11990} |
9. | MligTC455_36604 | 20 | 0.43 | Mlig455_025571 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_025571 {REF} {Length: 1241} {NoTransDecoderORF} {RNA1509_47691} {RNA1310_134162} {RNA815_32338} | |
10. | MligTC455_43986 | 93 | 1.93 | Mlig455_041502 | Neo: - Age: Down-Up-Up |
0.975 | - | - | - | - | 0.975 | - | Mlig455_041502 {REF} {Length: 1445} {NoTransDecoderORF} {RNA1310_32341.1} {RNA815_43781} | |
11. | MligTC455_53957 | 80 | 1.66 | Mlig455_068224 | Neo: - Age: Up-Down-Up |
0.97 | - | - | - | - | 0.970 | - | Mlig455_068224 {REF} {Length: 3283} {RNA1310_18298} {RNA815_25523} | |
12. | MligTC455_07318 | 34 | 0.72 | Mlig455_056720, Mlig455_060298 | Neo: - Age: - Region-enriched R2: 11.278/0.00008 Regeneration-downregulated R2: -4.848 Regeneration-depleted R2: -4.848 |
0.968 | - | - | - | - | 0.968 | - | Mlig455_056720 {REF} {Length: 2957} {RNA1310_123874} {RNA815_45268} Mlig455_060298 {REF} {Length: 3078} {RNA1310_82897} {RNA815_45268} |
|
13. | MligTC455_42010 | 89 | 1.85 | Mlig455_040323 | Neo: - Age: Up-Down-Down |
SEC23IP | 0.967 | - | - | - | - | 0.967 | - | Mlig455_040323 {REF} {Length: 3149} {TRANSSPLICED} {Pfam: DDHD domain [PF02862.19, score=163.9]; SAM domain (Sterile alpha motif) [PF00536.32, score=29.1]; SAM domain (Sterile alpha motif) [PF07647.19, score=21.0]; WWE domain [PF02825.22, score=20.1]} {Human: ENSG00000107651, SEC23IP, SEC23 interacting protein, [RH, Score=489, Expect=7e-159]; ENSG00000085788, DDHD2, DDHD domain containing 2, [RH, Score=476, Expect=2e-157]} {Mouse: ENSMUSG00000055319, Sec23ip, Sec23 interacting protein, [RH, Score=492, Expect=2e-160]; ENSMUSG00000061313, Ddhd2, DDHD domain containing 2, [RH, Score=470, Expect=2e-155]} {Dmel: FBgn0031990, PAPLA1, Phosphatidic Acid Phospholipase A1, [RH, Score=258, Expect=2e-75]} {Celegans: WBGene00019747, ipla-1, Intracelllar PhosphoLipase A family; Intracellular phospholipase A1, [Score=97.4, Expect=1e-20]} {Smed: dd_Smed_v6_4014_0_1, dd_Smed_v6_4014_0_1, [RH, Score=287, Expect=9e-83]} {RNA1509_38825} {RNA1310_9070.1} {RNA815_7099} |
14. | MligTC455_13088 | 55 | 1.14 | Mlig455_036251 | Neo: - Age: Down-Up-Down |
0.964 | - | - | - | - | 0.964 | - | Mlig455_036251 {REF} {Length: 1486} {NoTransDecoderORF} {RNA1509_42954} {RNA1310_144} {RNA815_48560} | |
15. | MligTC455_39275 | 12 | 0.26 | Mlig455_065877 | Neo: Int S/G2/M Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_065877 {REF} {Length: 2285} {NoTransDecoderORF} {RNA1509_24420} {RNA1310_29076} {RNA815_19982} | |
16. | MligTC455_42365 | 56 | 1.17 | Mlig455_037334 | Neo: - Age: - |
CHRNA3 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_037334 {REF} {Length: 3103} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=226.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=224.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=376, Expect=9e-124]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=372, Expect=2e-122]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=360, Expect=9e-118]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=382, Expect=2e-126]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=374, Expect=2e-123]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=451, Expect=2e-153]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=384, Expect=3e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [RH, Score=660, Expect=0.0]} {RNA1509_45903} {RNA1310_11151} {RNA815_10044.1} |
17. | MligTC455_00404 | 6 | 0.12 | Mlig455_021809 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_021809 {REF} {Length: 2141} {Pfam: Essential protein Yae1, N terminal [PF09811.11, score=41.6]} {RNA1310_38198} | |
18. | MligTC455_43925 | 14 | 0.28 | Mlig455_007983 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_007983 {REF} {Length: 2821} {RNA1310_91563} | |
19. | MligTC455_09723 | 43 | 0.89 | Mlig455_048052, Mlig455_048071 | Neo: - Age: Up-Down-Down |
0.951 | - | - | - | - | 0.951 | - | Mlig455_048052 {REF} {Length: 3592} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=110.8]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.6]; Glycine rich protein family [PF07172.13, score=21.2]} {Dmel: FBgn0033579, CG13229, [Score=121, Expect=1e-29]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=135, Expect=2e-34]} {Smed: dd_Smed_v6_24203_0_1, dd_Smed_v6_24203_0_1, [Score=204, Expect=1e-60]} {RNA1509_18576} {RNA1310_81440} {RNA815_16348} Mlig455_048071 {REF} {Length: 4002} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=110.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=58.2]; Glycine rich protein family [PF07172.13, score=21.9]} {Dmel: FBgn0033579, CG13229, [Score=119, Expect=5e-29]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=131, Expect=4e-33]} {Smed: dd_Smed_v6_24203_0_1, dd_Smed_v6_24203_0_1, [Score=202, Expect=8e-60]} {RNA1509_18576} {RNA1310_81440} {RNA815_16348} |